PCSA (STOCKS)
Processa Pharmaceuticals, Inc. Common
$2.780000
+0.010000 (+0.36%)
Prev close: $2.770000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- George K. Ng
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7.69M
- Employees
- 13
- P/E (TTM)
- -0.17
- P/B (TTM)
- 1.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-2.57 | $-1.53 | -1.0400 | -67.97% |
|
Sep 2025 (Q3)
|
$-1.75 | $-2.04 | +0.2900 | +14.22% |
|
Jun 2025 (Q2)
|
$-6.25 | $-5.87 | -0.3850 | -6.56% |
|
Mar 2025 (Q1)
|
$-7.50 | $-19.64 | +12.1350 | +61.80% |
Financial Statements
| Operating Income/Loss | -$13.99M |
| Income/Loss From Continuing Operations After Tax | -$13.56M |
| Income/Loss From Continuing Operations Before Tax | -$13.56M |
| Net Income/Loss | -$13.56M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$13.56M |
| Net Income/Loss Available To Common Stockholders, Basic | -$13.56M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$10.36 |
| Diluted Earnings Per Share | -$10.36 |
| Basic Average Shares | 1,309,271 |
| Diluted Average Shares | 1,309,271 |
| Assets | $7.81M |
| Current Assets | $5.67M |
| Noncurrent Assets | $2.14M |
| Fixed Assets | $3.81K |
| Non-current Prepaid Expenses | $993.70K |
| Other Non-current Assets | $1.15M |
| Liabilities | $2.24M |
| Current Liabilities | $2.24M |
| Accounts Payable | $1.06M |
| Other Current Liabilities | $1.18M |
| Noncurrent Liabilities | $0.00 |
| Equity | $5.58M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.58M |
| Liabilities And Equity | $7.81M |
| Net Cash Flow From Operating Activities | -$11.39M |
| Net Cash Flow From Operating Activities, Continuing | -$11.39M |
| Net Cash Flow From Investing Activities | -$850.00K |
| Net Cash Flow From Investing Activities, Continuing | -$850.00K |
| Net Cash Flow From Financing Activities | $16.58M |
| Net Cash Flow From Financing Activities, Continuing | $16.58M |
| Net Cash Flow | $4.35M |
| Net Cash Flow, Continuing | $4.35M |
| Comprehensive Income/Loss | -$13.56M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$13.56M |
| Other Comprehensive Income/Loss | $0.00 |